CHU Nancy
Vandœuvre-lès-Nancy, France
NCT Number: NCT05691725
Antisynthetase syndrome (AS) is a rare overlapping myositis characterized by cellular and humoral autoimmune responses directed against aminoacyl-tRNA synthetases. A pathogenic role of neutrophils was described during inflammatory myopathies, with increased netosis correlated with disease activity and muscle damage. Higher number of alveolar neutrophils was observed in patients with rapidly progressive forms of interstitial lung disease.
Peripheral neutrophils could represent a simple biomarker of severity and activity in patients with antisynthetase syndrome.
The main objective is to compare circulating neutrophils between severe and non severe patients with antisynthetase syndrome. Secondary objectives are: 1) to evaluate correlation between circulating neutrophils and organ-specific severity, 2) to compare circulating neutrophils at time of diagnosis and circulating neutrophils after 6 months of treatment in patients with antisynthetase syndrome.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Vandœuvre-lès-Nancy, France
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Time frame: at diagnosis (Day 0)
circulating neutrophils values (number of cells/mm3)
Time frame: at diagnosis (Day 0)
composite criteria of global severity: severe interstitial lung disease (ILD) and/or severe muscular disease
Time frame: at 6 months of follow-up
circulating neutrophils values (number of cells/mm3)
Time frame: at diagnosis (Day 0)
%predicted FVC values in patients with ILD
Time frame: at diagnosis (Day 0)
%predicted DLCO values in patients with ILD
Time frame: at diagnosis (Day 0)
manual muscle testing (MMT) grading in patients muscle involvement
Time frame: at diagnosis (Day 0)
CPK values (U/L) in patients muscle involvement
Central Hospital, Nancy, France
Other
Evaluation of Peripheral Neutrophils in Patients With Antisynthetase Syndrome
Acronym: NEUTROSAS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05523167
Active Idiopathic Inflammatory Myopathy, Antisynthetase Syndrome
Phoenix, Arizona, United States
View Trial DetailsNCT07662265
Antisynthetase Syndrome, Antisynthetase syndrome
Beijing, Beijing Municipality, China
View Trial DetailsNCT05989399
Antisynthetase Syndrome, Antisynthetase syndrome
Nancy, France
View Trial DetailsNCT05979441
Active Idiopathic Inflammatory Myopathy, Antisynthetase Syndrome
Phoenix, Arizona, United States
View Trial Details